Issue contents

Current issue
Last 12 issues
All issues

Topics

Annual Prescrire Awards
Advancing healthcare policy
Positions
Mediator° - the criminal trial
Drugs to avoid: 2022 update
Spotlight

About Prescrire

Who are we?
How we work
AMP: non-profit
Financing
No conflicts of interest
Where to find us
About Prescrire International
Testimonials
Prescrire events
A global network

Offers

Subscribe now
Solidarity Subscription Rate
Subscribers: register online
Prescrire's other products
Free Special Edition
Sign up to receive the newsletter

english.prescrire.org > Spotlight > Archives : 2013 > "Safer naming, labelling and packaging of medicines": a conference in Paris on Thursday 10th October, organised by IMSN

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2013 : 1 | 30 | 60

Spotlight

100 most recent
Archives
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005

"Safer naming, labelling and packaging of medicines":
a conference in Paris on Thursday 10th October, organised by IMSN

The Paris Satellite conference of the International Medication Safety Network will feature a public debate on the role of drug regulatory agencies and health authorities in assessing and preventing the risks of medication errors.
> Click here for details and to register online.

Sitemap |
Terms of use |
Contact
|Top of page

Spotlight: Archives

Spotlight

"Safer naming, labelling and packaging of medicines": a conference in Paris on Thursday 10th October, organised by IMSN

The Paris Satellite conference of the International Medication Safety Network will feature a public debate on the role of drug regulatory agencies and health authorities in assessing and preventing the risks of medication errors. > Click here for details and to register online.

"Safer naming, labelling and packaging of medicines":
a conference in Paris on Thursday 10th October, organised by IMSN

The Paris Satellite conference of the International Medication Safety Network will feature a public debate on the role of drug regulatory agencies and health authorities in assessing and preventing the risks of medication errors.
> Click here for details and to register online.